Login to Your Account



TGA move to regulate autologous stem cell therapies is long overdue, industry says

By Tamra Sami
Staff Writer

Tuesday, November 7, 2017

PERTH, Australia – Companies in the regenerative medicine space have long been pushing the TGA to regulate autologous cell and tissue products in Australia, and they strongly support the agency’s moves toward stronger regulation.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription